Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| HeartBeam, Inc.BEAT · Entity 9039 | CFO | July 24, 2026 | July 24, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
HeartBeam, Inc.
Report date July 24, 2026 · Filed July 24, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 239,990 |
Reported balance
After 2026-07-24 transaction · row 1
1 source rowRow 1 · 2026-07-24 · Grant · Acquired 167,760 · Balance 239,990 F1: Represents Restricted Stock Units ("RSUs") granted on July 24, 2026 under the HeartBeam, Inc. 2022 Equity Incentive Plan. The RSUs vested in full on the grant date and relate to the settlement of the 2025 Bonus Program, whereby Executives received shares-in-lieu-of-cash. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents Restricted Stock Units ("RSUs") granted on July 24, 2026 under the HeartBeam, Inc. 2022 Equity Incentive Plan. The RSUs vested in full on the grant date and relate to the settlement of the 2025 Bonus Program, whereby Executives received shares-in-lieu-of-cash.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 24, 2026 Filed Jul 24, 2026 20:54 UTC | HeartBeam, Inc. BEAT · Entity 9039 | GrantCommon Stock | 167,760 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-081455 · ownership.xml · nonDerivative · entry 1 Cruickshank Tim · CIK 0002038418 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 239,990 F1 · shares: Represents Restricted Stock Units ("RSUs") granted on July 24, 2026 under the HeartBeam, Inc. 2022 Equity Incentive Plan. The RSUs vested in full on the grant date and relate to the settlement of the 2025 Bonus Program, whereby Executives received shares-in-lieu-of-cash. Read SEC document |
| April 16, 2026 Filed Apr 17, 2026 00:48 UTC | HeartBeam, Inc. BEAT · Entity 9039 | PurchaseCommon Stock | 31,250 | $0.80 | $25,000.00 |
DisclosureSEC source: 0001213900-26-044841 · ownership.xml · nonDerivative · entry 1 Cruickshank Tim · CIK 0002038418 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,230 F1 · shares: These shares were purchased in connection with the Registrant's underwritten public offering of 12,500,000 shares of common stock. Titan Partners, a division of American Capital Partners, acted as the sole bookrunner for the offering, which priced on April 14, 2026, and closed on April 16, 2026. F2 · balance_after: Includes 23,333 RSUs which have vested as per the Form 4 filed on October 3, 2025. Read SEC document |
| February 09, 2026 Filed Mar 23, 2026 21:35 UTC | HeartBeam, Inc. BEAT · Entity 9039 | GrantCommon Stock (right to buy) · Derivative | 53,104 | $0.00 Strike: $1.45 | $0.00 |
DisclosureSEC source: 0001213900-26-033034 · ownership.xml · derivative · entry 1 Cruickshank Tim · CIK 0002038418 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,104 Underlying: Common Stock · 53,104 shares Expires 2036-01-01 F1 · derivative.exercise_date: Granted options on February 9, 2026 (the "Special Option"), one half of the total number of shares of common stock (the "Shares") subject to the Special Option shall vest on March 31, 2026, the three-month anniversary of the vesting commencement date beginning January 1, 2026, and the remaining Shares of common stock shall vest on June 30, 2026, the six-month anniversary of the vesting commencement date. These options have been issued from the Company's 2022 Equity Incentive Plan. Read SEC document |
| April 07, 2025 Filed May 1, 2025 15:06 UTC | HeartBeam, Inc. BEAT · Entity 9039 | GrantCommon Stock (right to buy) · Derivative | 150,000 | $0.00 Strike: $1.65 | $0.00 |
DisclosureSEC source: 0001213900-25-038175 · ownership.xml · derivative · entry 1 Cruickshank Tim · CIK 0002038418 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 550,000 Underlying: Common Stock · 150,000 shares Expires 2035-04-07 F1 · derivative.exercise_date: Granted 150,000 options on April 7, 2025, which are scheduled to vest over 4 years with 25% vesting on April 7, 2025, and the remainder vesting and exercisable monthly thereafter. These options have been issued from the Company's 2022 Equity Incentive Plan. Read SEC document |
| February 14, 2025 Filed Feb 22, 2025 00:55 UTC | HeartBeam, Inc. BEAT · Entity 9039 | PurchaseCommon Stock | 17,647 | $1.70 | $29,999.90 |
DisclosureSEC source: 0001628280-25-007239 · wk-form4_1740185708.xml · nonDerivative · entry 1 Cruickshank Tim · CIK 0002038418 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,647 F1 · shares: These shares were purchased in the Issuers offering which closed on February 14, 2025 Read SEC document |
| September 25, 2024 Filed Feb 22, 2025 00:55 UTC | HeartBeam, Inc. BEAT · Entity 9039 | GrantCommon Stock (right to buy) · Derivative | 400,000 | $2.28 Strike: $2.28 | $912,000.00 |
DisclosureSEC source: 0001628280-25-007239 · wk-form4_1740185708.xml · derivative · entry 2 Cruickshank Tim · CIK 0002038418 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 400,000 Underlying: Common Stock · 400,000 shares Expires 2034-09-25 F2 · derivative.exercise_date: Granted 400,000 options on September 25, 2024, which are scheduled to vest over 4 years with 25% vesting on September 26, 2025, and the remainder vesting and exercisable monthly thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.